125559-00-4 
 
1020412-43-4 
 
1-4-({6-({7-amino-3-(2-hydroxy-2-methylpropyl)-3.5.8-triazatricyclo7.4.0.02,6trideca-1(9),2(6),4,7,10,12-hexaen-4-yl}methyl)-N-ethylamino-6-oxohexylamino}carbonyl)cyclohexylmethyl}-1H-pyrrole-2,5-dione 
[1]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-WO2018/140831,2018,A2Locationinpatent:Paragraph0638;0639
125559-00-4 
 
C29H38N6O4 
 
2-amino-N8-(5-((6-(4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carboxamido)hexanamido)methyl)pyridin-3-yl)-N4,N4-dipropyl-3H-benzobazepine-4,8-dicarboxamide 
[1]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-US2018/258048,2018,A1Locationinpatent:Paragraph0605-0607
125559-00-4 
 
(S)-2-amino-N<SUP>1</SUP>-(4-(5-amino-6-((4-morpholinopyridin-3-yl)carbamoyl)pyrazin-2-yl)benzyl)-N<SUP>5</SUP>-(2-(3-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-3-oxopropoxy)ethyl)pentanediamidetrihydrochloride 
 
(S)-N1-(4-(5-amino-6-((4-morpholinopyridin-3-yl)carbamoyl)pyrazin-2-yl)benzyl)-2-(6-(4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)-cyclohexane-1-carboxamido)hexanamido)-N5-(2-(3-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-3-oxopropoxy)ethyl)pentanediamide 
[1]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-WO2018/227018,2018,A1Locationinpatent:Paragraph00385;00393
[2]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-WO2018/227023,2018,A1Locationinpatent:Paragraph0612
125559-00-4 
 
C44H49N11O8*3ClH 
 
3-amino-6-(4-(2-((2S)-2-(6-(4-((2,5-dioxo-2,5-diliydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carboxamido)hexanamido)-6-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)hexanamido)ethyl)phenyl)-N-(4-morpholinopyridin-3-yl)pyrazine-2-carboxamide 
[1]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-WO2018/227018,2018,A1Locationinpatent:Paragraph00395;00401